Patents by Inventor Max MEDINA-RAMIREZ

Max MEDINA-RAMIREZ has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11344618
    Abstract: The invention relates to an isolated, recombinant or synthetic polypeptide comprising an Env polypeptide of an HIV virus, the Env polypeptide comprising at least the amino acid residues K275, D276 and R278, wherein said numbering is according to the HxB2 reference sequence having the amino acid sequence of SEQ ID NO: 1.
    Type: Grant
    Filed: August 27, 2018
    Date of Patent: May 31, 2022
    Assignee: Academisch Medisch Centrum
    Inventors: Max Medina-Ramirez, Rogier Sanders
  • Publication number: 20200353069
    Abstract: The invention relates to an isolated, recombinant or synthetic polypeptide comprising an Env polypeptide of an HIV virus, the Env polypeptide comprising at least the amino acid residues K275, D276 and R278, wherein said numbering is according to the HxB2 reference sequence having the amino acid sequence of SEQ ID NO: 1.
    Type: Application
    Filed: August 27, 2018
    Publication date: November 12, 2020
    Inventors: Max MEDINA-RAMIREZ, Rogier SANDERS